Nimustine
Antineoplastic agent especially effective against malignant brain tumors. The resistance which brain tumor cells acquire to the initial effectiveness of this drug can be partially overcome by the simultaneous use of membrane-modifying agents such as reserpine, calcium antagonists such as nicardipine or verapamil, or the calmodulin inhibitor, trifluoperazine. The drug has also been used in combination with other antineoplastic agents or with radiotherapy for the treatment of various neoplasms.
Year introduced: 1989
PubMed search builder options
Subheadings:
Tree Number(s): D02.065.950.594.550, D02.654.692.550
MeSH Unique ID: D015376
Registry Number: 0S726V972K
Entry Terms:
Previous Indexing:
Pharmacologic Action: